| Předmět: |
|
| Zdroj: |
Hepatitis Weekly; 6/5/2023, p56-56, 1p |
| Abstrakt: |
Multiple doses will be administered over a 48-hour period. |
| Interventions: |
| Drug: Acetaminophen/Naproxen Sodium Fixed Combination |
| •Placebo Comparator: Placebo |
| Participants will receive oral doses of two placebo tablets taken with water. Keywords: Acetaminophen Therapy; Acetanilides; Analgesics; Anilides; Blood Pressure; Bunionectomy; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Hemodynamics; Naphthaleneacetic Acids; Naproxen; Naproxen Therapy; Neurologic Manifestations; Opioids; Pain; Pain Management; Pain Medicine; Pharmaceuticals; Placebos; Post-Operative Pain; Risk and Prevention; Surgery EN Acetaminophen Therapy Acetanilides Analgesics Anilides Blood Pressure Bunionectomy Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Hemodynamics Naphthaleneacetic Acids Naproxen Naproxen Therapy Neurologic Manifestations Opioids Pain Pain Management Pain Medicine Pharmaceuticals Placebos Post-Operative Pain Risk and Prevention Surgery 56 56 1 06/05/23 20230605 NES 230605 2023 JUN 5 (NewsRx) -- By a News Reporter-Staff News Editor at Hepatitis Weekly -- Staff editors report on the newly launched clinical trial, NCT05868122, which has the following summary description: "The purpose of this study is to evaluate effectiveness of a fixed combination of acetaminophen/naproxen sodium compared with placebo for reduction of pain when administered as multiple doses over a 48-hour period.". [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
